Northern Rockies Medical Center, INC.
Northern Rockies Medical Center, INC. was paid $543K by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 60% of everything it billed.
CUT BANK, MT 59427
Next to other Critical Access Hospital providers in Montana
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,022 | $83K | |
| 2019 | 11,924 | $78K | |
| 2020 | 10,652 | $62K | |
| 2021 | 10,699 | $69K | |
| 2022 | 11,678 | $84K | |
| 2023 | 11,656 | $94K | |
| 2024incomplete | 8,160 | $72K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 60% | 13,026 | 11,909 | $324K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 3,855 | 3,419 | $121K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.9% | 4,222 | 3,894 | $21K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.4% | 4,390 | 1,257 | $13K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.5% | 953 | 762 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 171 | 153 | $6K |
| 80053 | Comprehensive metabolic panel | 1.0% | 6,658 | 5,924 | $6K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 138 | 108 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 964 | 491 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,017 | 3,643 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 61 | 42 | $3K |
| 85027 | <1% | 3,601 | 3,184 | $3K |
59 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 6,971 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,798 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 595 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,067 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 609 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 831 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 983 | $2K |
| 81001 | <1% | 2,974 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 263 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,129 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,424 | $875.04 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 801 | $711.51 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,539 | $607.40 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 471 | $557.49 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 564 | $541.24 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,059 | $504.85 |
| 85651 | <1% | 262 | $493.61 | |
| 87081 | <1% | 159 | $485.46 | |
| 84439 | <1% | 575 | $397.13 | |
| 73610 | <1% | 14 | $250.16 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,495 | $247.36 |
| 71045 | Radiologic examination, chest; single view | <1% | 225 | $235.80 |
| 73030 | <1% | 13 | $234.32 | |
| 97161 | <1% | 100 | $209.40 | |
| 87420 | <1% | 88 | $180.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,036 | $170.95 |
| 81025 | <1% | 462 | $106.64 | |
| 84484 | <1% | 409 | $105.30 | |
| 86140 | <1% | 158 | $101.84 | |
| 82607 | <1% | 56 | $100.18 | |
| 80061 | Lipid panel | <1% | 1,822 | $98.10 |
| 83690 | <1% | 492 | $77.40 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 403 | $73.80 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 280 | $68.39 |
| 83655 | <1% | 35 | $46.80 | |
| 87186 | <1% | 12 | $41.88 | |
| 85018 | <1% | 35 | $40.50 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 286 | $35.10 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 271 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 32 | $0.00 |
| 83735 | 0% | 14 | $0.00 | |
| 83605 | 0% | 38 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 188 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 35 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 42 | $0.00 |
| 82150 | 0% | 98 | $0.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 25 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 39 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 32 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 24 | $0.00 |
| 85610 | 0% | 201 | $0.00 | |
| 86431 | 0% | 43 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 13 | $0.00 |
| 73630 | 0% | 13 | $0.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 49 | $0.00 |
| 82652 | 0% | 23 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 32 | $0.00 |
| 86038 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Northern Rockies Medical Center, INC | Cut Bank, MT | $497K |
| Liberty County Hospital and Nursing Home, INC | Chester, MT | $31K |
| Northern Rockies Medical Center, INC. | Cut Bank, MT | $0.00 |
| Liberty County Hospital and Nursing Home, INC | Chester, MT | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.